News Releases

NervGen Pharma Grants Stock Options

Vancouver, British Columbia–(Newsfile Corp. – May 31, 2022) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to

Read More »